CClinicalTrials.gg
CompletedNCT05357131Updated Jul 6, 2023

Neurophysiological Correlates of Dissociation Induced by Virtual Reality Hypnosis.

An interventional study of Hypnosis without VR (HYP) and Hypnosis with VR (VRH) in Healthy Volunteers, sponsored by University of Liege. Completed at 1 site in Belgium. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-06.

Sponsored by University of Liege · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Hypnosis and virtual reality are potential tools in treating acute pain. Nevertheless, the neurophysiological correlates of such tools used together, i.e. 'virtual reality hypnosis' (VRH) (Patterson et al., 2004) remain mostly understudied. This study aims to improve our knowledge and understanding of the dissociation (i.e., a mental separation of components of behaviours that normally would be processed together) occurring during VRH. This is a randomized controlled study that will be conducted on healthy participants. As the final goal is to propose such a tool in the clinical context, a clinical application will also be carried out subsequently.

Thus the principal outcome is to study dissociation in the context of VRH from a behavioral and neurophysiological point of view.

Secondary objectives aim at identifying factors that influence the dissociative effect seen in VRH, as well as measuring traits of hypnotisability, absorption, immersive abilities, dissociation trait and state, pain, and anxiety levels that might impact the effectiveness of such a tool.

Read the detailed description

The protocol will follow the following steps:

  1. Before the experiment:

    • A medical screening of the medical history and of any concomitant medications will be performed to eligibility.
    • The 6-item Elkins Hypnotisability Scale (EHS) will be used to assess participant hypnotisability.
    • Questionnaire sur la Propension à l'Immersion (QPI) will be used to assess participant immersion tendency.
  2. Experimental session: Cross-over and within-participant control design i. Visual Analogue Scale (VAS) :

    • Anxiety.
    • Pain. ii. EEG Resting-state (5-Min.). iii. EEG VRH or EEG Hypnosis alone (HYP) (15-Min.). iv. Adverse Events (AE) during the protocol will be recorded. v. Narrative recording. vi. VAS :
    • Dissociation
    • Absorption
    • Pain
    • Anxiety
    • Arousal/wakefulness
    • Automaticity vii. Time perception (open question) viii. CyberSickness (CSQ) (only if VRH) ix. Presence Questionnaire x. Satisfaction questionnaire xi. Washout Phase (30-Min.) during which we will administer :
    • Six-item State-Trait Anxiety Inventory (STAI-6) .
    • Tellegen Absorption Scale .
    • Dissociative Experience Scales (DES) . xii. VAS:
    • Anxiety
    • Pain xiv. Adverse Events during the protocol will be recorded. xv. Narrative recording. xvi. EEG HYP or EEG VRH Phase (15-Min.). xvii. VAS:
    • Dissociation
    • Absorption
    • Pain
    • Anxiety
    • Arousal/wakefulness
    • Time perception xviii. CSQ (only if VRH) xix. Presence Questionnaire. xx. Satisfaction Questionnaire .
02

Conditions studied

  • Healthy Volunteers

Keywords

  • Virtual Reality
  • Hypnosis
  • Dissociation
03

In context

Dissociative Disorders

167 studies on the registry are indexed under Dissociative Disorders; 27 are open to participants now.

This study's enrollment of 68 is above the median of 40 across 123 interventional studies indexed under Dissociative Disorders.

Browse Dissociative Disorders studies →

Lead sponsor

University of Liege is the lead sponsor of 242 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Subject more than 18 years old and equal or less than 65 years old.

Exclusion Criteria:

  1. Low auditory and/or visual acuity precludes the use of the device.
  2. Head or face wounds precluding the use of the device.
  3. Schizophrenia, dissociative disorder or any other psychiatric disorder.
  4. Non-proficiency in French (Research language).
  5. Patient under 18 years old.
  6. Phobia of deep water.
  7. Allergy to cutaneous electrodes.
  8. Chronic pain and/or chronic analgesics consumption.
  9. Medication affecting the autonomic nervous system.
  10. Dizziness.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
68 participants (actual)

Study arms

  • Experimental
    Healthy Volunteers - Hypnosis without VR (HYP )

    Cross-over and within-participant control design: Participants will receive recorded hypnosis without VR.

    Behavioral: Hypnosis without VR (HYP)

  • Experimental
    Healthy Volunteers - Hypnosis with VR (VRH)

    Cross-over and within-participant control design: Participants will receive hypnosis with VR.

    Device: Hypnosis with VR (VRH)

Interventions

  • BehavioralHypnosis without VR (HYP)

    HYP will last for 15 minutes including an induction phase of 5 minutes. The hypnotic audio script "Heaven of Peace" developped/recorded by Pr. M-E. Faymonville will be used.

  • DeviceHypnosis with VR (VRH)

    The VRH intervention will use the Aqua video session developed by Oncomfort.

06

What researchers measure

Primary outcomes

  1. Dissociation state

    Corresponds to a dissociation between the bodily sensations and the actual environment that one feels in a particular situation. will be assessed with a numerical rating scale (0= no dissociation; 10 = dissociation from environment).

    Time frame: During the procedure

Secondary outcomes

  1. Dissociation trait

    The amount of dissociation one experiences in one's daily life. Will be assessed with the Dissociative Experience Scale, the higher the score, the more one experiences dissociation in one's daily life.

    Time frame: During the procedure

  2. Hypnotisability

    The susceptibility one has concerning hypnosis. Will be assessed with the Elkins Hypnotizability Scale. A score : 0-3 : low hypnotizability 4-7: medium hypnotizability 8-11 : high hypnotizability 12 : very high hypnotizability

    Time frame: During the procedure

  3. Absorption trait

    The tendency to become fully involved in a perceptual, imaginative or ideational experience. Will be assessed with the Tellegen Absorption Scale, the higher the score the higher the absorption in the daily life.

    Time frame: During the procedure

  4. Anxiety trait

    Level of anxiety one experiences in one's daily life. Will be assessed with the STAI-6 questionnaire. The higher the score, the higher the anxiety one feels in one's daily life.

    Time frame: During the procedure

  5. Immersion propensity (trait)

    Immersion propensity is the amount of sensory input the virtual reality system creates. Will be assessed with the Immersion Propensity questionnaire. The higher the score, the more one is immersed in the virtual environments.

    Time frame: During the procedure

  6. Anxiety state

    The amount of anxiety one experiences in a particular situation. Will be assessed with a visual analogy scale. a score = 0 means no anxiety at all, while a score = 10 means most anxiety ever felt.

    Time frame: During the procedure

  7. Absorption state

    The amount of absroption one experiences in a particular situation. Will be assessed with a numercial rating scale, 0 = no absorption; 10 = fully absorption by the experience.

    Time frame: During the procedure

  8. Pain intensity

    The amount of pain one experiences in a particular situation. Will be assessed with a visual analogy scale, 0= no pain at all; 10= worst pain imaginable.

    Time frame: During the procedure

  9. Automaticity

    A non-voluntary response related to the content of a communication that is intended to be a suggestion. Will be assessed with a numerical rating scale : 0= perfect control; 10 = passive witness.

    Time frame: During the procedure

  10. Arousal/wakefulness

    The amount of arousal one experiences in a particular situation. Will be assessed with a visual analogy scale, 0=not aroused, awaked; 10 = completely aroused, awake.

    Time frame: During the procedure

  11. Time perception

    Open-ended question about one's impression of the duration of the VHR and HYP sessions.

    Time frame: During the procedure

  12. Cybersickness

    Assesses the sickness one might experience after the VRH. Will be assessed with the Cybersickness questionnaire. The higher the score, the more one has experience sickness during the VRH.

    Time frame: During the procedure

  13. Presence

    Refers to the degree to which the subject experiences being in the virtual environment. Will be assessed with the presence questionnaire, the higher the score the higher one has the feeling of really being in the virtual environment.

    Time frame: During the procedure

  14. Satisfaction of the participant

    Assesses the overall satisfaction one has had with the VRH and HYP session. Will be assessed by a self-made satisfaction questionnaire, the higher the score, the more one is satisfied with the experience.

    Time frame: During the procedure

07

Study locations

1 site
  • CHU of Liège
    Liège, 4000, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05357131
Lead sponsor
University of Liege
Collaborators
Oncomfort, Biowin
Responsible party
Audrey Vanhaudenhuyse (PhD, Responsible of the Sensation and Perception Research Group, in the GIGA CONSCIOUSNESS department, University of Liege) — Principal investigator
First posted
May 2, 2022
Start date
Jun 8, 2022
Primary completion
Jun 14, 2023
Completion
Jun 14, 2023
Last update
Jul 6, 2023

Study contacts

Audrey VANHAUDENHUYSE, PhD
principal investigator · CHU of Liège

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion